Kezar Life Sciences Inc (KZR) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-2.70x
Kezar Life Sciences Inc (KZR) has a Cash Flow-to-Debt Ratio of -2.70x as of March 2026, meaning its operating cash flow of $-7.45 Million could theoretically repay -3% of its total liabilities ($2.76 Million) in one year. See Kezar Life Sciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-2.70x
Operating CF / Total Liabilities
Operating Cash Flow
$-7.45 Million
USD
Total Liabilities
$2.76 Million
USD
Data as of
Mar 2026
Most recent filing
Kezar Life Sciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Kezar Life Sciences Inc across 10 annual periods. For the full cash flow conversion analysis, see Kezar Life Sciences Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Kezar Life Sciences Inc (2016–2025)
Year-by-year debt coverage analysis for Kezar Life Sciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -7.88x | $-51.78 Million | $6.57 Million | ▼ -194.7% |
| 2024 | -2.67x | $-74.21 Million | $27.77 Million | ▼ -10.2% |
| 2023 | -2.43x | $-81.64 Million | $33.66 Million | ▼ -22.4% |
| 2022 | -1.98x | $-58.85 Million | $29.70 Million | ▲ +1.7% |
| 2021 | -2.02x | $-42.44 Million | $21.06 Million | ▲ +40.7% |
| 2020 | -3.40x | $-36.95 Million | $10.86 Million | ▼ -30.5% |
| 2019 | -2.61x | $-29.88 Million | $11.47 Million | ▲ +26.3% |
| 2018 | -3.53x | $-20.79 Million | $5.88 Million | ▼ -3381.6% |
| 2017 | -0.10x | $-8.11 Million | $79.91 Million | ▲ +70.0% |
| 2016 | -0.34x | $-9.76 Million | $28.85 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.